ABSTRACT
Purpose
To design and fabricate multicomponent amorphous electrospun nanofibers for synergistically improving the dissolution rate and permeation profiles of poorly water-soluble drugs.
Methods
Nanofibers were designed to be composed of a poorly water soluble drug, helicid, a hydrophilic polymer polyvinylpyrrolidone as filament-forming matrix, sodium dodecyl sulfate as transmembrane enhancer and mannitol as taste masking agent, and were prepared from hot aqueous co-dissolving solutions of them. An elevated temperature electrospinning process was developed to fabricate the composite nanofibers, which were characterized using FESEM, DSC, XRD, ATR-FTIR, in vitro dissolution and permeation tests.
Results
The composite nanofibers were homogeneous with smooth surfaces and uniform structure, and the components were combined together in an amorphous state because of the favorable interactions such as hydrogen bonding, electrostatic interaction and hydrophobic interactions among them. In vitro dissolution and permeation tests demonstrated that the composite nanofibers had a dissolution rate over 26-fold faster than that of crude helicid particles and a 10-fold higher permeation rate across sublingual mucosa.
Conclusions
A new type of amorphous material in the form of nanofibers was prepared from hot aqueous solutions of multiple ingredients using an electrospinning process. The amorphous nanofibers were able to improve the dissolution rate and permeation rate of helicid.
Similar content being viewed by others
REFERENCES
Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today. 2008;13:606–12.
Rasenack N, Muller BW. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm Res. 2002;19:1894–900.
Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12:1068–75.
Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Del Rev. 2007;59:617–30.
Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003;18:113–20.
Farokhzad OC. Nanotechnology for drug delivery: the perfect partnership. Expert Opin Drug Del. 2008;5:927–9.
Farokhzad OC, Langer R. Impact of Nanotechnology on Drug Delivery. ACS Nano. 2009;3:16–20.
Moshfeghi AA, Peyman GA. Micro- and nanoparticulates. Adv Drug Deliv Rev. 2005;57:2047–52.
Merisko-Liversidge E, McGurk SL, Liversidge GG. Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin. Pharm Res. 2004;21:1545–53.
Yin L, Ding J, He C, Cui L, Tang C, Yin C. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials. 2009;30:5691–700.
Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release. 2009;133:238–44.
Li P, Hynes SR, Haefele TF, Pudipeddi M, Royce AE, Serajuddin AT. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug. J Pharm Sci. 2009;98:1750–64.
Merisko-Liversidge E, Liversidge GG. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol. 2008;36:43–8.
Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–20.
Yu DG, Shen XX, Branford-White C, White K, Zhu LM, Bligh SWA. Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers. Nanotechnology. 2009;20:055104.
Yu DG, Branford-White C, White K, Li XL, Zhu LM. Comparison of solid dispersions in drug delivery membranes from different processes. AAPS PharmSciTech. 2010;11:809–17.
Yu DG, Branford-White C, Li L, Wu XM, Zhu LM. The compatibility of acyclovir with the matrix polymer PAN in the electrospun nanofiber membrane. J Applied Polym Sci. 2010;117:1509–15.
Yu DG, Zhu LM, White K, Branford-White C. Electrospun nanofiber-based drug delivery systems. Health. 2009;1:67–75.
McKee MG, Layman JM, Cashion MP, Timothy EL. Phospholipid nonwoven electrospun membranes. Science. 2006;311:353–5.
Dzenis Y. Spinning continuous fibres for nanotechnology. Science. 2004;304:1917–9.
Rutledge GC, Fridrikh SV. Formation of fibers by electrospinning. Adv Drug Del Rev. 2007;59:1384–91.
Ji L, Saquing C, Khan SA, Zhang X. Preparation and characterization of silica nanoparticulate–polyacrylonitrile composite and porous nanofibers. Nanotechnology. 2008;19:085605.
Liu DY, Wang GL, Ma SC, Lin RC. Research on the pharmaceutical active components in Helicia Lour. Chin Tradit Herbal Drugs. 2004;35:593–5.
Yu DG, Yang XL, Wang Y, Li X, Xu HB. 3DP used for controlled-release helicid tablets. Chin Tradit Patent Med. 2007;29:679–83.
Chawla G, Bansal AK. Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives. Acta Pharm. 2008;58:257–74.
Whitehea K, Karr N, Mitragotri S. Safe and effective permeation enhancers for oral drug delivery. Pharm Res. 2008;25:1782–8.
Pongpeerapat A, Wanawongthai C, Tozuka Y, Moribe K, Ymamoto K. Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture. Int J Pharm. 2008;352:309–16.
Wanawongthai C, Pongpeerapat A, Higashi K, Tozuka Y, Moribea K, Yamamoto K. Nanoparticle formation from probucol/PVP/sodium alkyl sulfate co-ground mixture. Int J Pharm. 2009;376:169–75.
Li D, Xia Y. Electrospinning of nanofibers: reinventing the wheel? Adv Mater. 2004;16:1151–70.
Wang C, Chien HS, Hsu CH, Wang YC, Wang CT, Lu HA. Electrospinning of polyacrylonitrile solutions at elevated temperatures. Macromolecules. 2007;40:7973–83.
Givens SR, Gardner KH, Rabolt JF, Chase DB. High-temperature electrospinning of polyethylene microfibers from solution. Macromolecules. 2007;40:608–10.
Jadhav NR, Gaikwad VL, Nair KJ, Kadam HM. Glass transition temperature: basics and application in pharmaceutical sector. Asian J Pharm. 2009;3:82–9.
McKee MG, Elkins CL, Long TE. Influence of self-complementary hydrogen bonding on solution rheology/electrospinning relationships. Polymer. 2004;45:8705–15.
Murthy NS, Minor H, Bednarczyk C, Krimm S. Structure of the amorphous phase in oriented polymers. Macromolecules. 1993;26:1712–21.
Pongpeerapat A, Higashi K, Tozuka Y, Moribe K, Yamamoto K. Molecular interaction among probucol/PVP/SDS multicomponent system investigated by solid-state NMR. Pharm Res. 2006;23:2566–74.
Roscigno P, Asaro F, Pellizer G, Ortana O, Paduano L. Complex Formation between PVP and sodium decyl sulfate. Langmiur. 2003;19:9638–44.
Verreck G, Chun I, Peeters J, Rosenblatt J, Brewster ME. Preparation and characterization of nanofibers containing amorphous drug dispersion generated by electrostatic spinning. Pharm Res. 2003;20:810–7.
Ghebremeskel AN, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer–surfactant combinations using solubility parameters and testing the processability. Int J Pharm. 2007;328:119–29.
Goswami T, Jasti BR, Li X. Estimation of the theoretical pore sizes of the porcine oral mucosa for permeation of hydrophilic permeants. Arch Oral Biol. 2009;54:577–82.
Dhiman MK, Dhiman A, Sawant KK. Transbuccal delivery of 5-fluorouracil: permeation enhancement and pharmacokinetic study. AAPS PharmSciTech. 2009;10:258–65.
Chett DJ, Chen LH, Chien YW. Characterization of captopril sublingual permeation of preferred routes and mechanisms. J Pharm Sci. 2001;90:1868–77.
Nicolazzo JA, Reed BL, Finnin BC. Buccal penetration enhancers—How do they really work? J Control Release. 2005;105:1–15.
ACKNOWLEDGEMENTS
This work was financially supported by China Postdoctoral Science Foundation Project (Special NO. 200902195) and UK-CHINA Joint Laboratory for Therapeutic Textiles.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Yu, DG., Gao, LD., White, K. et al. Multicomponent Amorphous Nanofibers Electrospun from Hot Aqueous Solutions of a Poorly Soluble Drug. Pharm Res 27, 2466–2477 (2010). https://doi.org/10.1007/s11095-010-0239-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-010-0239-y